Rejuvenation Technologies Inc.
We extend telomeres to extend the human health span
Mountain View, United States · Founded 2016 · $10.6M raised
- Headquarters
- Mountain View, California
- Employees
- 1–10
- Founded
- 2016
- Website
- rejuvenationtech.com
- Total Funding
- $10.6M
- Last Round
- $10.6M SeedSep 2023
- Rounds
- 1
About
Delivery of TERT mRNA extends telomeres sufficiently in a few days to reverse over a decade of telomere shortening during normal aging. We are advancing TERT mRNA-based therapies to the clinic.
Summary
Rejuvenation Technologies Inc. is a Biotech company based in Mountain View, United States, founded in 2016. It has raised $10.6M in total across 1 round, most recently a $10.6M Seed round in Sep 2023. Investors include Khosla Ventures, Shanda and Asymmetry Ventures.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2023
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Global contract research organization providing comprehensive drug development and laboratory ser...